diaziquone has been researched along with Recrudescence in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baer, MR; Block, AW; Bloomfield, CD; Carroll, AJ; Farag, SS; Koduru, PR; Kolitz, JE; Larson, RA; Mayer, RJ; Moore, JO; Mrózek, K; Pettenati, MJ; Powell, BL; Ruppert, AS; Schiffer, CA; Stamberg, J; Stone, RM; Vardiman, JW | 1 |
| Burger, PC; Byar, DP; Green, SB; Mahaley, MS; Malkin, MG; Pistenmaa, DA; Ransohoff, J; Shapiro, WR; Strike, TA; Vogel, FS | 1 |
| Ball, H; Blessing, JA; Rettenmaier, M; Slayton, RE | 1 |
| Egorin, MJ; Lee, EJ; Nayar, MS; Schiffer, CA; Shulman, P; Van Echo, DA | 1 |
2 trial(s) available for diaziquone and Recrudescence
| Article | Year |
|---|---|
Outcome of induction and postremission therapy in younger adults with acute myeloid leukemia with normal karyotype: a cancer and leukemia group B study.
Topics: Acute Disease; Adolescent; Adult; Age Factors; Antineoplastic Combined Chemotherapy Protocols; Aziridines; Benzoquinones; Cyclophosphamide; Cytarabine; Daunorubicin; Etoposide; Female; Humans; Karyotyping; Leukemia, Myeloid; Male; Middle Aged; Mitoxantrone; Prognosis; Recurrence; Splenomegaly; Survival Analysis; Treatment Outcome | 2005 |
Superiority of PCNU over AZQ in the treatment of primary brain tumors: results of a prospective randomized trial (81-20) by the Brain Tumor Study Group.
Topics: Antineoplastic Agents; Aziridines; Benzoquinones; Brain Neoplasms; Child; Humans; Middle Aged; Nitrosourea Compounds; Prospective Studies; Recurrence; Survival Analysis | 1994 |
2 other study(ies) available for diaziquone and Recrudescence
| Article | Year |
|---|---|
A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent adenocarcinoma and adenosquamous carcinoma of the cervix. A Gynecologic Oncology Group study.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Agents; Aziridines; Benzoquinones; Carcinoma, Squamous Cell; Drug Evaluation; Drugs, Investigational; Female; Humans; Middle Aged; Recurrence; Uterine Cervical Neoplasms | 1989 |
Diaziquone given as a continuous infusion is an active agent for relapsed adult acute nonlymphocytic leukemia.
Topics: Acute Disease; Adolescent; Adult; Aged; Antineoplastic Agents; Aziridines; Azirines; Benzoquinones; Female; Humans; Kinetics; Leukemia; Male; Middle Aged; Platelet Count; Recurrence | 1986 |